Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001).
Matsui H, Ioka T, Takahashi T, Kawaoka T, Maeda Y, Yahara N, Kubo H, Nishimura T, Inokuchi T, Harada E, Shindo Y, Tokumitsu Y, Nakajima M, Takami T, Ito K, Tanaka H, Hamano K, Nagano H.
Matsui H, et al. Among authors: takahashi t.
Pancreas. 2024 Mar 4. doi: 10.1097/MPA.0000000000002323. Online ahead of print.
Pancreas. 2024.
PMID: 38530956